Health Ministry & NITI Aayog On Covishield-Covaxin Vaccine Mix-Up In Uttar Pradesh; ‘Significant Effect Unlikely If Doses Mixed,’ Says Centre

INDIA Team Latestly|

Significant adverse effects are "unlikely" if an individual's second Covid-19 vaccine dose is different from the first, the centre said on May 27 afternoon. "This should be looked into,” Dr VK Paul, the Chair of NEGVAC (National Expert Group on Vaccine Administration for COVID-19), said. Earlier this month 20 UP villagers were given Bharat Biotech's Covaxin when they went for the mandatory second dose. They were administered Covishield on their first visit in early April. Days before the UP mix-up a 72-year-old Maharashtra man was also given mixed doses. The effectiveness, or impact, of mixing vaccines is still a subject of global research. India has administered over 20 crore vaccine doses so far.

City Petrol Diesel
New Delhi 97.76 88.30
Kolkata 97.63 91.15
Mumbai 103.89 95.79
Chennai 98.88 92.89
View all
Company Price Change Value
Axis Banks 1050.00 50.00 533.00
Reliance 1050.00 33.00 533.00
Samsung 1050.00 33.00 533.00
Currency Price Change
USD 74.5500 -0.05
GBP 104.3300 0.31